RECRUITING

Drug Effects on Mood and Behavior - Expectancy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will examine the effects of a single low dose of the 5HT2A agonist LSD (Lysergic Acid Diethylamide) (13 µg) or placebo in individuals who are or are not explicitly told what drug they will receive. Although it is known that expectancies strongly influence subjective responses to most drugs, no studies have examined expectancies on response to a very low dose of LSD. This is especially important in the context of 'microdosing' of drugs. People who practice microdosing typically do so with strong expectations of positive effects, making it difficult to determine whether there is a pharmacological effect. To minimize expectancies in the laboratory, participants are usually not told exactly what drug they will receive (i.e., double-blind), but given a range of possibilities. In the present study, the study team will test half the subjects under single-blind conditions, where the participants (but not the research assistant) will know exactly what they are receiving. Other subjects will receive the usual instructions. Healthy volunteers will receive either a marginally detectable dose of LSD (13 micrograms) or placebo, under conditions where they i) know for sure what drug they are receiving or ii) where the identity of the drug is uncertain. Four groups of subjects (N=12 each) will attend single 4-hour laboratory session. The study team will examine subjective and behavioral responses to the drug in each of four conditions (Known-Drug; Known-Placebo; Uncertain-Drug; Uncertain-Placebo).

Official Title

Drug Effects on Mood and Behavior - Expectancy

Quick Facts

Study Start:2025-06-26
Study Completion:2026-06-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07061886

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * English Fluency
  2. * High school education or higher
  3. * BMI between 19-30 kg/m2
  1. * Individuals with a medical condition contraindicating study participation as determined by the study physician (e.g., liver disease, abnormal EKG, liver or cardiovascular disease)
  2. * High blood pressure (\>140/90)
  3. * Current suicidal ideation or suicide attempt in past 12 months
  4. * Past year severe substance use disorder
  5. * Personal or first-degree relative with history of psychosis
  6. * Currently taking any psychiatric medication (for conventional antidepressants must be off for ≥ 2 weeks)
  7. * Active panic disorder
  8. * Severe obsessive-compulsive disorder
  9. * Severe post-traumatic stress disorder
  10. * Women who are pregnant or planning to become pregnant

Contacts and Locations

Study Contact

Hanna Molla
CONTACT
7737023560
hmolla@uchicago.edu

Principal Investigator

Hanna Molla
PRINCIPAL_INVESTIGATOR
University of Chicago

Study Locations (Sites)

University of Chicago
Chicago, Illinois, 60637
United States

Collaborators and Investigators

Sponsor: University of Chicago

  • Hanna Molla, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-26
Study Completion Date2026-06-05

Study Record Updates

Study Start Date2025-06-26
Study Completion Date2026-06-05

Terms related to this study

Keywords Provided by Researchers

  • Healthy Adults

Additional Relevant MeSH Terms

  • LSD